BioCentury | Jul 25, 2019
Distillery Therapeutics

A tumor-targeted Bavencio conjugate with enhanced antitumor efficacy treat first-line renal cell carcinoma, Merkel cell carcinoma and urothelial cancer. SolaranRx Inc. has SRX-1177...
BioCentury | May 18, 2015
Clinical News

SRX-1177 regulatory update

...FDA granted Orphan Drug designation to SRX-1177 to treat stage IIB-IV malignant melanoma. SRX-1177 is in... identify and deliver targeted radiation to receptor-expressing tumors. SolaranRx Inc. , Albuquerque, N.M. Product: SRX-1177...
Items per page:
1 - 2 of 2